Author pages are created from data sourced from our academic publisher partnerships and public sources.
A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU.
BACKGROUND Limited information is available on the health-care utilization of hospitalized patients with community-acquired pneumonia (CAP) depending on the location of care. Our aim was to compare… Expand
Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study.
BACKGROUND To our knowledge, no previous study has systematically examined pneumonia-related and pneumonia-unrelated mortality. This study was performed to identify the cause(s) of death and to… Expand
COPD is associated with increased mortality in patients with community-acquired pneumonia
Patients with chronic obstructive pulmonary disease (COPD) who develop community-acquired pneumonia (CAP) may experience worse clinical outcomes. However, COPD is not included as a distinct diagnosis… Expand
The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
BackgroundRecent studies suggest that HMG-CoA reductase inhibitors ("statins") may have beneficial effects for patients at risk for some types of infections. We examined the effect of prior… Expand
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia
Recent studies suggest that statins and angiotensin-converting enzyme (ACE) inhibitors may have beneficial effects for some types of infections. The present study aimed to examine the association of… Expand
Streptococcus pneumoniae Translocates into the Myocardium and Forms Unique Microlesions That Disrupt Cardiac Function
Hospitalization of the elderly for invasive pneumococcal disease is frequently accompanied by the occurrence of an adverse cardiac event; these are primarily new or worsened heart failure and cardiac… Expand
Impact of Previous Statin and Angiotensin II Receptor Blocker Use on Mortality in Patients Hospitalized with Sepsis
Study Objective. To examine the effect of previous outpatient use of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors (statins) and/or angiotensin II receptor blockers (ARBs) on 30‐day… Expand
Transport of volume, heat, and salt towards the Arctic in the Faroe Current 1993–2013
- B. Hansen, K. M. H. Larsen, H. Hátún, R. Kristiansen, E. Mortensen, S. Østerhus
- 22 September 2015
Abstract. The flow of warm and saline water from the Atlantic Ocean, across the Greenland–Scotland Ridge, into the Nordic Seas – the Atlantic inflow – is split into three separate branches. The most… Expand
Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia.
- E. Mortensen, W. Kapoor, C. Chang, M. Fine
- Clinical infectious diseases : an official…
- 15 December 2003
Although studies have assessed short-term mortality among patients with community-acquired pneumonia, there is limited data on prognosis and risk factors that affect long-term mortality. The… Expand
Impact of statins and ACE inhibitors on mortality after COPD exacerbations
BackgroundThe purpose of our study was to examine the association of prior outpatient use of statins and angiotensin converting enzyme (ACE) inhibitors on mortality for subjects ≥ 65 years of age… Expand